Inspire Medical Systems, Inc. to Present at the BofA Securities Health Care Conference 2023
Inspire Medical Systems (NYSE: INSP) has announced its participation at the BofA Securities Health Care Conference 2023, scheduled for May 10, 2023, at 11:40 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Inspire Medical Systems (NYSE: INSP) has announced its participation at the BofA Securities Health Care Conference 2023, scheduled for May 10, 2023, at 11:40 a.m. ET. The presentation will showcase its innovative solutions for obstructive sleep apnea, including the proprietary Inspire therapy, the only FDA-approved neurostimulation technology for treating moderate to severe cases. Interested parties can access the live webcast here. A replay will be available for two weeks on Inspire’s Investor website, which can be visited here.
Details
News Market Reaction – INSP
The recorded move for INSP in the trading session of this news was +1.18%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MINNEAPOLIS, April 26, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the BofA Securities Health Care Conference 2023 on Wednesday, May 10, 2023.
Inspire is scheduled to present at 11:40 a.m. Eastern Time. The presentation will be accessible via a live webcast here.
A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.